SCHEMBL15782864

SCHEMBL15782864

CCc1cc2cc(O)cc(O)c2c(O)c1C(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
CYP3A4 P08684 3/20 0.48
HPGD P15428 1/20 0.48
POLB P06746 2/20 0.45
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
PTGS1 P23219 1/20 0.41
DRD3 P35462 1/20 0.41
ANTXR2 P58335 1/20 0.38
PRKCI P41743 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN11 Q06124 1/20 0.38
HSD17B1 P14061 2/20 0.37
KDM4E B2RXH2 1/20 0.35
ABL1 P00519 1/20 0.35
MAPT P10636 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24079182 0.87 MEN1 (0.46) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL12800168 0.80 CYP3A4 (0.52) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL15782873 0.79 MEN1 (0.50) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL29406040 0.79 ANTXR2 (0.39) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL12948360 0.78 MEN1 (0.53) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL15782810 0.77 MEN1 (0.70) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL17866954 0.77 ANTXR2 (0.37) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL16226706 0.74 POLB (0.55) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL12800172 0.71 CYP3A4 (0.42) MEN1KMT2ACYP3A4HPGDPOLB
SCHEMBL15782861 0.70 KCNA3 (0.42) POLBPRKCIKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10669244-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-06-02 US disclosed
US-9884830-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-02-06 US disclosed
EP-3138831-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF President and Fellows of Harvard College (US) 2017-03-08 EP disclosed
US-20160340325-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-11-24 US disclosed
US-9365493-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-06-14 US disclosed
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF TET1, TET3, MYC MEN1 1643/4885KMT2A 535/4885CYP3A4 1517/4885
US-10669244-B2 Synthesis of tetracyclines and analogues thereof TET1, TET3, MYC MEN1 1643/4885KMT2A 535/4885CYP3A4 1517/4885
US-20160340325-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF TET1, TET3, MYC MEN1 1643/4885KMT2A 535/4885CYP3A4 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.